Country: United States
Language: English
Source: NLM (National Library of Medicine)
GLYBURIDE (UNII: SX6K58TVWC) (GLYBURIDE - UNII:SX6K58TVWC)
REMEDYREPACK INC.
GLYBURIDE
GLYBURIDE 2.5 mg
ORAL
PRESCRIPTION DRUG
Glyburide tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glyburide tablets are contraindicated in patients with: - Known hypersensitivity or allergy to the drug. - Diabetic ketoacidosis, with or without coma. This condition should be treated with insulin. - Type I diabetes mellitus. - Concomitant administration of bosentan.
Glyburide tablets USP, 1.25 mg are white, round, and functionally scored tablets engraved with BP 606 on one side and 1.25 on the other side. They are supplied as follows: NDC 52817-120-10 bottles of 100 Glyburide tablets USP, 2.5 mg are peach-colored, round, and functionally scored tablets engraved with BP 607 on one side and 2.5 on the other side. They are supplied as follows: NDC 52817-121-10 bottles of 100 Glyburide tablets USP, 5 mg are green-colored, round, and functionally scored tablets engraved with BP 608 on one side and 5 on the other side. They are supplied as follows: NDC 52817-122-10 bottles of 100 NDC 52817-122-00 bottles of 1000 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in tight, light-resistant container. Keep container tightly closed. Distributed by: TruPharma, LLC Tampa, FL 33609 Manufactured by: Pharmadax Inc. Guangdong Province, P.R. China 528244 Rev. 07/16
Abbreviated New Drug Application
GLYBURIDE- GLYBURIDE TABLET REMEDYREPACK INC. ---------- DESCRIPTION Glyburide tablets USP contain glyburide, which is an oral blood-glucose-lowering drug of the sulfonylurea class. Glyburide is a white, crystalline compound. The chemical name for glyburide is 1- [[p-[2-(5-chloro-o-anisamido)ethyl]phenyl]-sulfonyl]-3-cyclohexylurea and the molecular weight is 493.99. It has the following structural formula: Molecular formula: C H ClN O S Each tablet, for oral administration, contains 1.25 mg, 2.5 mg or 5 mg of glyburide. In addition, each tablet contains the following inactive ingredients: lactose monohydrate, magnesium stearate, sodium starch glycolate, and talc. In addition, the 2.5 MG contains red iron oxide and yellow iron oxide; the 5 MG contains D&C yellow No. 10 aluminum lake and FD&C blue No. 1/brilliant blue FCF aluminum lake. CLINICAL PHARMACOLOGY ACTIONS Glyburide appears to lower the blood glucose acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. The mechanism by which glyburide lowers blood glucose during long-term administration has not been clearly established. With chronic administration in Type II diabetic patients, the blood glucose lowering effect persists despite a gradual decline in the insulin secretory response to the drug. Extrapancreatic effects may be involved in the mechanism of action of oral sulfonylurea hypoglycemic drugs. The combination of glyburide and metformin may have a synergistic effect, since both agents act to improve glucose tolerance by different but complementary mechanisms. Some patients who are initially responsive to oral hypoglycemic drugs, including glyburide, may become unresponsive or poorly responsive over time. Alternatively, glyburide tablets may be effective in some patients who have become unresponsive to one or more other sulfonylurea drugs. In addition to its blood glucose lowering actions, glyburide produces a mild diuresis by enhancement of renal free water clearance. Read the complete document